This document provides updates and guidance on MERS (Middle East Respiratory Syndrome) cases. It summarizes that MERS is caused by a novel coronavirus first identified in 2012. As of June 2013, there have been over 50 confirmed cases across several countries, with over 30 related deaths. The original source and full transmission mechanisms are still unknown but appear to involve animal to human and limited human to human transmission. It provides case definitions and guidance for healthcare providers on infection control, testing, treatment and notifying health departments of suspected cases.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Most people who fall sick with COVID-19 will experience mild to moderate symptoms and recover without special treatment.
This is a kind of seminar presentation that covers the basic information about COVID 19 including virus origin, the molecular structure of the virus. It also presents adequate information on the outbreak happened all over the world and the mathematical model for prediction of what will happen later. The other part of the presentation contains a cellular mechanism of how the virus invades our body. Finally, treatment strategies are clarified.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Most people who fall sick with COVID-19 will experience mild to moderate symptoms and recover without special treatment.
This is a kind of seminar presentation that covers the basic information about COVID 19 including virus origin, the molecular structure of the virus. It also presents adequate information on the outbreak happened all over the world and the mathematical model for prediction of what will happen later. The other part of the presentation contains a cellular mechanism of how the virus invades our body. Finally, treatment strategies are clarified.
KEY TAKEAWAYS:
1. ABOUT COVID-19
Biology of the COVID-19, virulence,
diagnosis and treatment
2. PREVENTION MEASURES
How can one stay unaffected from
the current and future outbreaks
3. STATS ABOUT COVID-19
Patterns of this infection
worldwide
THE CORONAVIRUS STORY: COVID - 19 PANDEMIC OUTBREAK SERIES I Episode 1 I Tim...MhdAfz
For more such informative content, go to https://scifitechify.blogspot.com/. For more such informative presentations go to https://scifitechify.blogspot.com/
This a series of videos about the recently discovered coronavirus and its pandemic outbreak. NEXT POST ON: THE CORONAVIRUS STORY:
COVID - 19 PANDEMIC OUTBREAK SERIES I Episode 2 I Structure of the Virus
For more such informative presentations go to https://scifitechify.blogspot.com/
Coronavirus disease, transmission of COVID 19, signs and symptoms of COVID 19, how it affects respiratory system, pathogenesis of COVID 19, prevention from COVID, vaccine development. COVID 19 pandemic
Bedside to Bench: How Clinical Imaging of Patients with COVID-19 is Informing...Scintica Instrumentation
In this webinar presented by Scintica Instrumentation, we took a look at both clinical and preclinical imaging of COVID-19. Starting with a review of current literature surrounding clinical imaging and post-mortem histological autopsy studies of patients with COVID-19, this webinar examined how these studies can inform prospective preclinical investigations using novel imaging tools to better understand COVID-19 pathophysiology
In light of the rise in MERS CoV cases in the Middle East the Yale-Tulane ESF-8 Planning and Response Program has produced this special report. It was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.
COVID-19, CORONA VIRUS, SARS.MERS, HUMAN CORONA VIRUS, CHARACTERISTICS OF CORONA VIRUS, HISTORY OF EPIDEMICS, TIMELINE OF COVID 19 OUTBREAK, GLOBAL SITUATION, INDIAN SITUATION, RISK ASSESSMENT OF COVID 19, SIGN AND SYMPTOMS, COMPLICATION, DIAGNOSIS, MANAGEMENT, PREVENTION, HAND HYGIENE, PPE, ONGOING RESEARCH OF ICMR, ISOLATION, QUARANTINE, SOCIAL DISTANCING
KEY TAKEAWAYS:
1. ABOUT COVID-19
Biology of the COVID-19, virulence,
diagnosis and treatment
2. PREVENTION MEASURES
How can one stay unaffected from
the current and future outbreaks
3. STATS ABOUT COVID-19
Patterns of this infection
worldwide
THE CORONAVIRUS STORY: COVID - 19 PANDEMIC OUTBREAK SERIES I Episode 1 I Tim...MhdAfz
For more such informative content, go to https://scifitechify.blogspot.com/. For more such informative presentations go to https://scifitechify.blogspot.com/
This a series of videos about the recently discovered coronavirus and its pandemic outbreak. NEXT POST ON: THE CORONAVIRUS STORY:
COVID - 19 PANDEMIC OUTBREAK SERIES I Episode 2 I Structure of the Virus
For more such informative presentations go to https://scifitechify.blogspot.com/
Coronavirus disease, transmission of COVID 19, signs and symptoms of COVID 19, how it affects respiratory system, pathogenesis of COVID 19, prevention from COVID, vaccine development. COVID 19 pandemic
Bedside to Bench: How Clinical Imaging of Patients with COVID-19 is Informing...Scintica Instrumentation
In this webinar presented by Scintica Instrumentation, we took a look at both clinical and preclinical imaging of COVID-19. Starting with a review of current literature surrounding clinical imaging and post-mortem histological autopsy studies of patients with COVID-19, this webinar examined how these studies can inform prospective preclinical investigations using novel imaging tools to better understand COVID-19 pathophysiology
In light of the rise in MERS CoV cases in the Middle East the Yale-Tulane ESF-8 Planning and Response Program has produced this special report. It was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.
COVID-19, CORONA VIRUS, SARS.MERS, HUMAN CORONA VIRUS, CHARACTERISTICS OF CORONA VIRUS, HISTORY OF EPIDEMICS, TIMELINE OF COVID 19 OUTBREAK, GLOBAL SITUATION, INDIAN SITUATION, RISK ASSESSMENT OF COVID 19, SIGN AND SYMPTOMS, COMPLICATION, DIAGNOSIS, MANAGEMENT, PREVENTION, HAND HYGIENE, PPE, ONGOING RESEARCH OF ICMR, ISOLATION, QUARANTINE, SOCIAL DISTANCING
Lecture By:
Dr. Ahmed Qureshi, MS, FACS, MBA, PCIC
Head, Infection Prevention & Control Department,
Arar Central Hospital, Arar, KSA
Regional Coordinator , IP & C, North Zone , KSA
Lecture by:
Dr. Satti M. Saleh
Chief of Infectious Diseases Department MGH Director of IC Unit Meeqat General hospital
CBAHI SIT Member
Medical Director Meeqat General Hospital
MIDDLE EAST RESPIRATORY SYNDROME CORONA VIRUS (MERS CoV)Dhruvendra Pandey
Middle East Respiratory Syndrome, countries affected by MERS virus, preventive and control strategies for MERS infection, recommendation for healthcare professionals and hospitals in case of MERS corona virus infection, time trend of different events in corona virus infection, MERS Cov is associated with camels, Saudi Arabia guideline for travellers to haj and umrah, MERS CoV Vaccine
REVIEW Open AccessMERS coronavirus diagnostics,epidemio.docxmichael591
REVIEW Open Access
MERS coronavirus: diagnostics,
epidemiology and transmission
Ian M. Mackay1,2,3* and Katherine E. Arden2
Abstract
The first known cases of Middle East respiratory syndrome (MERS), associated with infection by a novel coronavirus (CoV),
occurred in 2012 in Jordan but were reported retrospectively. The case first to be publicly reported was from Jeddah, in
the Kingdom of Saudi Arabia (KSA). Since then, MERS-CoV sequences have been found in a bat and in many dromedary
camels (DC). MERS-CoV is enzootic in DC across the Arabian Peninsula and in parts of Africa, causing mild upper
respiratory tract illness in its camel reservoir and sporadic, but relatively rare human infections. Precisely how virus transmits
to humans remains unknown but close and lengthy exposure appears to be a requirement. The KSA is the focal point of
MERS, with the majority of human cases. In humans, MERS is mostly known as a lower respiratory tract (LRT) disease
involving fever, cough, breathing difficulties and pneumonia that may progress to acute respiratory distress syndrome,
multiorgan failure and death in 20 % to 40 % of those infected. However, MERS-CoV has also been detected in mild and
influenza-like illnesses and in those with no signs or symptoms. Older males most obviously suffer severe disease and
MERS patients often have comorbidities. Compared to severe acute respiratory syndrome (SARS), another sometimes- fatal
zoonotic coronavirus disease that has since disappeared, MERS progresses more rapidly to respiratory failure and acute
kidney injury (it also has an affinity for growth in kidney cells under laboratory conditions), is more frequently reported in
patients with underlying disease and is more often fatal. Most human cases of MERS have been linked to lapses in
infection prevention and control (IPC) in healthcare settings, with approximately 20 % of all virus detections reported
among healthcare workers (HCWs) and higher exposures in those with occupations that bring them into close contact
with camels. Sero-surveys have found widespread evidence of past infection in adult camels and limited past exposure
among humans. Sensitive, validated reverse transcriptase real-time polymerase chain reaction (RT-rtPCR)-based diagnostics
have been available almost from the start of the emergence of MERS. While the basic virology of MERS-CoV has advanced
over the past three years, understanding of the interplay between camel, environment, and human remains limited.
Keywords: Middle East respiratory syndrome, Coronavirus, MERS, Epidemiology, Diagnostics, Transmission
Background
An email from Dr Ali Mohamed Zaki, an Egyptian
virologist working at the Dr Soliman Fakeeh Hospital in
Jeddah in the Kingdom of Saudi Arabia (KSA) an-
nounced the first culture of a new coronavirus to the
world. The email was published on the website of the
professional emerging diseases (ProMED) network on
20thSeptember 2012 [1] (Fig. 1) and described the first
reported case.
Corona virus was first identified as a cause of the common cold in 1960. Until 2002, the virus was considered a relatively simple, nonfatal virus.Over the last three decades there have been three attacks of three different coronaviruses, SARS-CoV, MERS CoV and the recent one 2019 novel coronavirus (2019-nCoV).
Medcrave - MERS coronavirus - current statusMedCrave
CDC: Centers for Disease Control; MERS-CoV: Middle
East Respiratory Syndrome Coronavirus; RT-PCR: Reverse
Transcriptase Polymerase Chain Reaction; VLP: Virus Like
Particles.
Recently, a new virus started to infect certain individuals in the Middle-East. It was soon identified as a previously unknown coronavirus that caused severe respiratory disease with a high rate of mortality. This virus, MERS-CoV, is still closely watched by health authorities as it has the potential to evolve and cause a major epidemic.
MR. MOHAMMAD TALAL AL JOHANY
RESPIRATORY THERAPIST
Meqaat Hospital Madina
POST TEST
https://forms.gle/apSH6sR5mRTwRvjJ6
https://youtube.com/channel/UCUlJw6wef_dhQi3TXNTkn6g
OVID-19 Management experience
What we learned from bedside experience in COVID-19 treatment
Dr. Essam A. Salem, ICU Registrar, Meeqat GENERAL.HOSPITAL, Head OF ICU Unit Meeqat General Hospital
Hassan Mohamed Ali
Associate professor of anesthesia and pain management, Anesthesia department, Cairo University.
MB.B.ch, M Sc, M.D, FCAI, DESA
Meeqat General Hospital, Madinah Munawarah
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
2. ?What is MERS
CDC continues to work closely with the World
Health Organization (WHO) and other partners
to better understand the public health risk
Middle East Respiratorypresented by
-). MERSCoV-Coronavirus (MERSSyndrome
CoV used to be called “novel coronavirus,” or
“nCoV
3. What is the new human
coronavirus?
A novel coronavirus was identified in 2012 as
the cause of respiratory illness in people. The
new virus is a beta coronavirus. It is different
from any other coronavirus previously found in
people.
4. Is this virus the same as the
SARS virus?
the samenotisnovel coronavirusNo. The
virus that caused severe acute respiratory
syndrome (SARS) in 2003. However, like the
SARS virus, the novel coronavirus is most
similar to those found in bats. CDC is still
learning about this new virus.
5.
6.
7. The first cluster of two cases
The first cluster of two cases, both fatal,
occurred near Amman, Jordan, in April 2012.
Stored samples from these two cases tested
positive retrospectively for the novel
coronavirus. This cluster was temporally
associated with cases of illness among
workers in a hospital
8. A second cluster
A second cluster occurred in October 2012, in
Saudi Arabia. Of the four individuals in the
household, three were laboratory-confirmed
cases, two of them died
9. MERS Cases and Deaths,
April 2012 - May 2013
Current as of June 11, 2013
Countries
Cases (Deaths)
France
2 (1)
Italy
3 (0)
Jordan
2 (2)
Qatar
2 (0)
Saudi Arabia
40 (26)
Tunisia
2 (0)
United Kingdom (UK)
3 (2)
United Arab Emirates (UAE)
1 (1)
Total
55 (32)
10. MERS Cases and Deaths,
April 2012 - Present
Countries Cases (Deaths)
France 2 (1)
Italy 3 (0)
Jordan 2 (2)
Qatar 2 (0)
Saudi Arabia 53 (32)
Tunisia 2 (0)
United Kingdom (UK) 3 (2)
United Arab Emirates
(UAE)
1 (1)
Total 68 (38)
Current as of June 21, 2013, 9:00 AM EDT
11. -The original source of MERS
,CoV
The original source of MERS-CoV, routes of
transmission to humans, and mode of human-
to-human transmission have not been
determined. Genetic sequencing to date has
determined the virus is most closely related to
coronaviruses detected in bats. CDC is
continuing to collaborate with WHO and
affected countries to better characterize the
epidemiology of MERS-CoV infection in
humans.
12. What are the symptoms of novel
coronavirus infection?
Most people who got infected with the novel
coronavirus developed severe acute
respiratory illness with symptoms of fever,
cough, and shortness of breath. Some
people were reported as having a mild
respiratory illness
14. Patient Under Investigation
(PUI)
A person with an acute respiratory infection,
which may include fever (≥ 38°C , 100.4°F)
and cough; AND
suspicion of pulmonary parenchymal disease
(e.g., pneumonia or acute respiratory distress
syndrome based on clinical or radiological
evidence of consolidation); AND
history of travel from the Arabian Peninsula or
neighboring countries* within 10 days; AND
15. Probable Case
A person fitting the definition above of a “Patient
Under Investigation” with clinical, radiological, or
histopathological evidence of pulmonary
parenchyma disease (e.g. pneumonia or ARDS)
but no possibility of laboratory confirmation either
because the patient or samples are not available
or there is no testing available for other respiratory
infections, AND
close contact with a laboratory confirmed case,
AND
not already explained by any other infection or
etiology, including all clinically indicated tests for
community-acquired pneumonia according to local
management guidelines.
16. Confirmed Case
A person with laboratory confirmation of
infection with the novel coronavirus.
17. Does the virus spread from person
to person?
The virus has been shown to spread between
people who are in close contact.
Transmission from infected patients to
healthcare personnel has also been
observed. Clusters of cases in Saudi Arabia,
Jordan, the UK and France are being
investigated.
18. modes of transmission
There is clear evidence of human-to-human
transmission, possibly involving different
modes of transmission such as droplet and
contact transmission. But further studies are
required to better understand the risks. The
efficiency of person-to-person transmission of
novel coronavirus is not well characterized.
19. Can I still travel to countries in the Arabian
Peninsula or neighboring countries
Yes. WHO and CDC have not issued travel
health warnings for any country related to
novel coronavirus
20. What if I recently traveled to
countries in the Arabian Peninsula
or
neighboring countries and got sick?
If you develop a fever and symptoms of
lower respiratory illness, such as cough or
shortness of breath, within 10 days after
traveling from countries in the Arabian
, you)1(Peninsula or neighboring countries
should see your healthcare provider and
mention your recent travel
21. What are the treatments?
There are no specific treatments for
illnesses caused by the novel
coronavirus. Medical care is
supportive and to help relieve
symptoms.
22. Is there a lab test?
Lab tests (polymerase chain reaction or
PCR) for the novel coronavirus are available at
CDC and other international labs. Otherwise,
these tests are not routinely available
23. What should healthcare
providers and health
departments do
For recommendations and guidance on the
case definitions; infection control, including
personal protective equipment guidance; case
investigation; and specimen collection and
shipment,
24. Infection control
recommendations for healthcare
settings
Until the transmission characteristics of the
novel coronavirus are better understood,
patients under investigation and probable and
confirmed cases should be managed
according to CDC’s infection control
recommendations for the coronavirus that
caused SARS.
25. For Healthcare Providers
Infection control recommendations for
healthcare settings
Standard, contact, and airborne precautions are
recommended for management of hospitalized
patients with known or suspected MERS-CoV
infection. These recommendations are
consistent with those recommended for the
coronavirus that caused severe acute
respiratory syndrome (SARS) in 2003. The
recommendations are based on available
information (as of June 10, 2013) and will be re-
evaluated and updated as needed when new
information becomes available